Glucose-lowering agents and reduced risk of incident non-alcoholic fatty liver disease: new insights.

ABSTRACT:

SUBMITTER: Mantovani A 

PROVIDER: S-EPMC8847873 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature